info@efcni.org

Other content tagged: research

“Small for Gestational Age” lowers cognitive performance from infancy to adulthood

Cognitive performance in childhood can be negatively impacted if an infant was Small for Gestational Age (SGA, birthweight <10% for gestation). As existing research did not show coinciding results on whether lower IQ scores continue to be present in adulthood, Eves et al. conducted an observational study to assess differences in IQ scores between SGA adults and Appropriate for Gestational Age (AGA) adults. The study compared the impact of low familial socioeconomic status and quality…
Read more

“Impact of Coronavirus/COVID-19 on special/intensive care for newborns – a parents’ perspective”

The worldwide study “Impact of Coronavirus/COVID-19 on special/intensive care for newborns – a parents’ perspective” is unique: It aims at exploring parents’ experiences related to the challenges caused by the current pandemic regarding the care of and access to their newborn baby – voices that are often overheard. The Coronavirus/COVID-19 pandemic creates exceptional challenges, especially for the care of the most vulnerable groups of patients – such as sick and preterm born children. It is therefore important to explore parents’…
Read more

Survive and Thrive: Transforming Care for Small and Sick Newborns

The webinar series “Survive and thrive: transforming care for small and sick newborns” by the World Health Organisation (WHO) and the United Nations Children’s Fund (UNICEF) has now come to an end. For the past four months, leading experts on neonatal health gave a detailed  insight into the findings collected in the report, and shared country experiences in improving quality of care for newborns and introduced WHO’s new standards of care for small and sick newborns. On May 6, EFCNI…
Read more

Applying a “living guidelines” approach to keep recommendations up to date

How can the WHO most efficiently keep its global recommendations up to date? BMJ Global Health has recently published the insightful article "Developing and applying a 'living guidelines' approach to WHO recommendations on maternal and perinatal health", describing how the WHO successfully developed and applied a ‘living guidelines’ approach to its maternal and perinatal health (MPH) recommendations, based on a systematic and continuous process of prioritisation and updating. The new dynamic approach uses an evidence-informed, consultative prioritisation process, rapid updating…
Read more

PARCA-R: Screening of cognitive and language delay in preterm born infants

The standardisation on over 6000 infants of the PARCA-R for the screening of cognitive and language delay has just been published in the Lancet Child & Adolescence Health. 6000 infants at the age of 2 were tested in cognitive and language development. PARCA-R stands for Parent Report of Children’s Abilities-Revised. It is a parent completed questionnaire that can be used to assess children's cognitive and language development at 24 months of age. The PARCA-R is used as an outcome measure…
Read more

Preterm babies are less likely to form romantic relationships in adulthood

Adults who were born preterm (under 37 weeks gestation) are less likely to have a romantic relationship, a sexual partner and experience parenthood than those born full term. The meta-analysis by researchers at the University of Warwick with data from up to 4.4 million adult participants showed that those born preterm are 28% less likely to ever be in a romantic relationship. A study of up to 4.4m adult participants has shown that those who were born preterm (under 37…
Read more

Series of RECAP cohorts – part 4: the NTNU Low Birth Weight Life study from Norway

In our  series about cohorts of the EU-funded project „Research on European Children and Adults born Preterm“ (RECAP preterm), we presented the Project Extreme Prematurity (PEP) from Norway. We are thrilled to share a second example from Norway with you, the Low Birth Weight Life study of the Norwegian University of Science and Technology (NTNU). Principal investigator Kari Anne I. Evensen, Associate Professor at the NTNU, told us what this study is all about.  The NTNU Low Birth Weight in…
Read more

Call for projects by the French Foundation for Cerebral palsy

The French Foundation for Cerebral Palsy "Fondation Paralysie Cérébrale", offers grants for research projects on Cerebral palsy and disorders that are associated with it (motor disorders, superior functions, epilepsy, sensory disorders, secondary orthopedic disorders, etc.). This call for proposals will projects with a total budget from €500,000 to €1.5 million for 3 to 5 years. Research that could receive funding may include large-scale projects in the field of clinical research, translational research, public health or social sciences, with the aim…
Read more

How the ESPR seeks to improve medical care and clinical practice in Paediatrics

Within the monthly topic ‘Medical care and clinical practice’ of our campaign 11 Months - 11 Topics, we present you the European Society for Paediatric Research (ESPR), an organisation which has been at the forefront of Paediatric medical care and innovation since 1958. As one of the oldest and most prolific Paediatric research societies in Europe, the ESPR co-organises annual conferences (the joint European Neonatal Societies’ Congress and European Academy of Paediatric Societies’ Congress), supports investigators with research grants, runs a…
Read more

EMA drafts guideline for medicinal products containing genetically modified cells – Feedback wanted!

The European Medicines Agency has released a draft guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells for public consultation. This guideline aims at defining scientific principles and shall provide guidance for the development and evaluation of medicinal products containing genetically modified cells intended for use in humans and presented for marketing authorisation. The guideline focuses on the quality, nonclinical aspects and safety and efficacy requirements of genetically modified cells developed as medicinal products. Please…
Read more